|We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.|
Edesa Biotech is a small Canadian company with a pipeline including a TLR4 antibody that is hoped to stop the "cytokine storm" in acute respiratory distress syndrome (ARDS).
Initial results (Sept 20, 2021) suggest it works well.
|© 2021 Knight Sac Media. Data provided by IEX, Alpha Vantage, Coinbase, Binance, Fintel and CityFALCON News|